However, Foundayo is specifically approved for weight management, not diabetes treatment
Patients with epilepsy who were not treated with ASMs had a significantly greater risk of T2DM than nonepileptic controls did (aHR, 1.70), and patients who were treated with ASMs had a significantly lower risk of T2DM than those who were not treated (all aHR 0.60) did (82)
It is sold as research-use-only material rather than as a medicine
The programs structure ensures that formulation selection supports treatment continuity and adherence while maintaining regulatory awareness
China Patent Application CN102134556 (A) Richie JP, Nichenametla S, Neidig W, Calcagnotto A, Haley JS, Schell TD, Muscat JE (2015) Randomized controlled trial of oral glutathione supplementation on body stores of glutathione